Recent News

• 02.10.2026 - Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results

Recent Filings

• 02.06.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.05.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities
• 01.30.2026 - 4 Statement of changes in beneficial ownership of securities